Search
Clinical Trials
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Ex
Immunovant IMVT-1401-2401
SynchNeuro Scalp
EMBOLISE
CITADEL
Publications
Featured Investigator
Sylvia Sudat
PhD
Dr. Sudat is a Sutter Health Epic data and analytic expert, and an informal content leader for the analytics team at Sutter’s Center for Health Systems Research